Filter
95
Text search:
MRC
South
Africa
Featured
Recommendations
6
New Publications
16
Language
Document type
No document type
55
Studies & Reports
23
Guidelines
12
Strategic & Response Plan
3
Fact sheets
2
Countries / Regions
South Africa
12
India
6
Ethiopia
2
Uganda
2
South Sudan
2
Kenya
2
Malawi
2
East and Southern Africa
2
Africa
2
Ghana
1
Philippines
1
Somalia
1
Zambia
1
Thailand
1
Gambia
1
Rwanda
1
Mozambique
1
Brazil
1
Burundi
1
Ukraine
1
Botswana
1
Angola
1
Myanmar / Burma
1
Yemen
1
Eastern Europe
1
Russia
1
Global
1
Authors & Publishers
Publication Years
Category
Countries
32
Clinical Guidelines
16
Public Health
4
Women & Child Health
3
Toolboxes
HIV
22
TB
14
COVID-19
9
Mental Health
7
Planetary Health
4
NCDs
4
Refugee
3
Disability
2
Ebola
2
Rapid Response
2
Conflict
1
AMR
1
Social Ethics
1
Caregiver
1
Pharmacy
1
NTDs
1
Masangane Case Study
The Vesper Society commissioned ARHAP to do research on the integrated Masangane HIV/AIDS programme affiliated with the Moravian Church in Eastern Cape, South Africa. Completed
...
PLOS ONE | https://doi.org/10.1371/journal.pone.0210937
February 5, 2019
Many African countries were amongst the most rapid to respond to the emerging threat of COVID-19, implementing large-scale interventions at very early stages of their epidemic. As demonstrated in this document using very simple models, this rapid mobilization and timeliness of implementing control m
...
The results of the SHINE trial have been published in the NEJM today. SHINE looked at whether treatment for children with minimal TB could be reduced from 6 months to 4 months. It found that the four month treatment was as good as the standard six months treatment for children with minimal TB
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are
...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w
...
Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention,
...
Vitamin A deficiency is a risk factor for blindness and for mortality from measles and diarrhoea in children aged 6–59 months. We aimed to estimate trends in the prevalence of vitamin A defi ciency between 1991 and 2013 and its mortality burden in low-income and middle-income countries.
This publication makes the case for working with men and women, boys and girls, together in an intentional and mutually reinforcing way that challenges gender norms in the pursuit of improved health and gender equality. In addition to providing a definition for the new concept of gender synchronizat
...
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant
...
HIV i-Base
July 2018
This document contains: The systematic reviews and GRADE assessments used at the Index-TB Guideline Panel in July 2015; The Evidence to Decision tables that record the Panel’s assessment and recommendations from
this meeting
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines up
...
Поэтому уже давно возникала мысль о том,что подробный комментарий по вопросам научных знаний и практическогоопыта, лежащих в основе политики ВОЗ по борьбе
...
treat TB
Description of Research Outputs, 2009 - 2014
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
A comprehensive compilation is provided of the medicinal plants of the Southeast Asian country of Myanmar (formerly Burma). This contribution, containing 123 families, 367 genera, and 472 species, was compiled from earlier treatments, monographs, books, and pamphlets, with some medicinal uses and pr
...
BMJ,Dodd PJ, et al. Thorax 2017;72:559–575. doi:10.1136/thoraxjnl-2016-209421
